Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial

Bartlett, 2002, Clinical practice. Antibiotic associated diarrhea, N Engl J Med, 346, 334, 10.1056/NEJMcp011603 McFarland, 2016, Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections, World J Gastroenterol, 22, 3078, 10.3748/wjg.v22.i11.3078 Cote, 2006, Antibiotic-associated diarrhoea, Expert Opin Drug Saf, 5, 361, 10.1517/14740338.5.3.361 McFarland, 1998, Epidemiology, risk factors and treatments for antibiotic-associated diarrhea, Dig Dis, 16, 292, 10.1159/000016879 Sammons, 2013, Clostridium difficile infection in children, JAMA Pediatr, 167, 567, 10.1001/jamapediatrics.2013.441 Högenauer, 1998, Mechanisms and management of antibiotic-associated diarrhea, Clin Infect Dis, 27, 702, 10.1086/514958 McFarland, 2006, Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease, Am J Gastroenterol, 101, 812, 10.1111/j.1572-0241.2006.00465.x Hill, 2014, Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nat Rev Gastroenterol Hepatol, 11, 506, 10.1038/nrgastro.2014.66 Surawicz, 2003, Probiotics, antibiotic associated diarrhoea and Clostridium difficile diarrhoea in humans, Best Pract Res Clin Gastroenterol, 17, 775, 10.1016/S1521-6918(03)00054-4 Szajewska, 2015, Systematic review and meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea, Aliment Pharmacol Ther, 42, 793, 10.1111/apt.13344 Szajewska, 2015, Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults, Aliment Pharmacol Ther, 42, 1149, 10.1111/apt.13404 Szajewska, 2016, Probiotics for the prevention of antibiotic-associated diarrhea in children, J Pediatr Gastroenterol Nutr, 62, 495, 10.1097/MPG.0000000000001081 Savino, 2015, Probiotics and gut health in infants: a preliminary case–control observational study about early treatment with Lactobacillus reuteri DSM 17938, Clin Chim Acta, 451, 82, 10.1016/j.cca.2015.02.027 Georgieva, 2015, Use of the probiotic Lactobacillus reuteri DSM 17938 in the prevention of antibiotic associated infections in hospitalized Bulgarian children: a randomized, controlled trial, IMAB—Annu Proc (Sci Pap), 21, 895 Kołodziej, 2017, Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial, BMJ Open, 7, 10.1136/bmjopen-2016-013928 Moher, 2010, CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials, BMJ, 340, c869, 10.1136/bmj.c869 Kotowska, 2005, Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial, Aliment Pharmacol Ther, 21, 583, 10.1111/j.1365-2036.2005.02356.x Szymański, 2008, Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial, Digestion, 78, 13, 10.1159/000151300 Ghanma, 2014, Amsterdam infant stool scale is more useful for assessing children who have not been toilet trained than Bristol stool scale, Acta Paediatr, 103, 91, 10.1111/apa.12422 Lewis, 1997, Stool form scale as a useful guide to intestinal transit time, Scand J Gastroenterol, 32, 920, 10.3109/00365529709011203 Vanderhoof, 1999, Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children, J Pediatr, 135, 564, 10.1016/S0022-3476(99)70053-3 Szymański, 2008, Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial, Digestion, 78, 13, 10.1159/000151300 Bin, 2015, The efficacy of Saccharomyces boulardii CNCM I-745 in addition to standard Helicobacter pylori eradication treatment in children, Pediatr Gastroenterol Hepatol Nutr, 18, 17, 10.5223/pghn.2015.18.1.17 Wanke, 2012, Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, doubleblind, placebo-controlled trial, J Pediatr, 161, 40, 10.1016/j.jpeds.2011.12.049 Urbańska, 2016, Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children, Aliment Pharmacol Ther, 43, 1025, 10.1111/apt.13590 Gutiérrez-Castrellón, 2017, Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: systematic review with network meta-analysis, Medicine (Balt), 96, e9375, 10.1097/MD.0000000000009375 Savino, 2010, Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo controlled trial, Pediatrics, 126, e526, 10.1542/peds.2010-0433 Coccorullo, 2010, Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study, J Pediatr, 157, 598, 10.1016/j.jpeds.2010.04.066 Neut, 2017, Antibiotic susceptibility of probiotic strains: is it reasonable to combine probiotics with antibiotics?, Med Mal Infect, 47, 477, 10.1016/j.medmal.2017.07.001